Compte-rendu du congrès de l'ISPOR 2017: Accès au marché des médicaments: Extraits de l'ISPOR 2017

The 22nd ISPOR (International society for phamacoeconomics and outcomes research) conference was held in Boston from May 20 to 24, 2017. A group of pharmacists, physicians and health economists attended the conference and reported some of the highlights and most striking points of this professionnal event. Market access is a domain that is developing and requires varied cooperations between payers, suppliers and users. This paper reports and explains some methods and economic evaluation tools that can be used, illustrated with concrete examples, such as the biosimilars or the medicine in oncology. It shows that a holistic approach is necessary to facilitate or not the access of innovative medicines and that the different schemes reported here are, however, highly dependent on the model of health of the considered geographical zone or on the given country.